Pharma giants from Johnson & Johnson to Novartis to Roche, looking for edges in speed and convenience, have unveiled self-injection options to replace intravenous infusions in the fields of cancer, ...

– Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment – “Today's approval reflects our ...

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...

If topical medications haven’t been strong enough to control your psoriasis, your dermatologist may recommend a biologic, a type of drug that targets the part of the immune system responsible for ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication of self-administered subcutaneous furosemide for patients with HF. The ...